A new oral Agent for the Therapy of multiple Sclerosis

被引：0
|
作者：
Borchers, Anja
机构：
来源：
NERVENHEILKUNDE | 2011年 / 30卷 / 12期
关键词：
TERIFLUNOMIDE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1019 / 1019
页数：1
相关论文
共 50 条
  • [1] Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis
    Venci, Jineane V.
    Gandhi, Mona A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (12) : 1697 - 1702
  • [2] Oral therapy for multiple sclerosis!
    de Seze, J.
    [J]. REVUE NEUROLOGIQUE, 2010, 166 (04) : 363 - 364
  • [3] Comment on "Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis"
    Bakshi, Rajesh
    Bischof, Dorina
    Klaft, Jan
    [J]. ANNALS OF PHARMACOTHERAPY, 2014, 48 (07) : 944 - 944
  • [4] ORAL DISEASE MODIFYING THERAPY FOR MULTIPLE SCLEROSIS; IS THIS THE NEW NORMAL?
    Johnson, B. H.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A290 - A291
  • [5] TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS
    Bencsik Krisztina
    Rozsa Csilla
    Vecsei Laszlo
    [J]. IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (3-4): : 79 - 87
  • [6] Response to Comment on "Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis"
    Venci, Jineane
    Gandhi, Mona A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2014, 48 (11) : 1537 - 1537
  • [7] Oral therapy approved for multiple sclerosis
    Traynor, Kate
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (09) : 744 - 744
  • [8] Teriflunomide for oral therapy in multiple sclerosis
    Papadopoulou, Athina
    Kappos, Ludwig
    Sprenger, Till
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (06) : 617 - 628
  • [9] Extending the Potential of the Treatment of Multiple Sclerosis with a New Agent for Oral Use – Teriflunomide (Aubagio)
    Khachanova N.V.
    Gorokhova T.V.
    [J]. Neuroscience and Behavioral Physiology, 2017, 47 (1) : 112 - 116
  • [10] New oral drugs for multiple sclerosis
    Gasperini, Claudio
    Ruggieri, S.
    [J]. NEUROLOGICAL SCIENCES, 2009, 30 : 179 - 183
12345